Michael Mullan

Michael Mullan is a biomedical researcher of the β-amyloid protein and its relation to Alzheimer’s disease. Mullan's Alzheimer research is well known among Biomedical Community. Dr. Mullan's Alzheimer research work ^[1] resulted in identifying the most widely known Swiss Mutation that is present in familial form. Transgenic Animal for Alzheimer Disease uses Swiss Mutation.

Dr. Mullan is currently the director^[2] of the Roskamp Institute in Sarasota, Florida. Under Dr. Mullan's guidelines the institute is carrying out cutting edge research in Alzheimer's, Traumatic Brain Research, Gulf War Illness and other neuropsychiatric disorder.

References

1. ^ "Mullan Alzheimer Research" (html). mullanalzheimer.com. http://www.mullanalzheimer.com. "Director: Michael Mullan, M.D. Ph.D" 
2. ^ "Who We Are: Executive Leadership" (html). roskampinstitute.com. http://www.roskampinstitute.com/about_who.html. "Director: Michael Mullan, M.D. Ph.D" 

External links

• About the Roskamp Institute on the rfdn.org website.
• About the Mullan's Alzheimer Research on the Mullan Alzheimer Research.

Persondata
Name	Mullan, Michael
Alternative names
Short description
Date of birth
Place of birth
Date of death
Place of death